Showing results (41-50 of 118) with videos related to

Sort By:
Pageof 12
Bio-Medical Materials and Engineering|December 10, 2008
Local induction of heat shock protein 70 (Hsp70) by proteasome inhibition confers chondroprotection during surgically induced osteoarthritis in the rat kneeStéphanie Etienne, Nadège Gaborit, Christel Henrionnet, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|July 16, 2013
Chondrocalcin is internalized by chondrocytes and triggers cartilage destruction via an interleukin-1β-dependent pathwayClaudie Bantsimba-Malanda, Justine Cottet, Patrick Netter, et al.
Expert Opinion on Drug Safety|July 26, 2021
Gastroenterological safety of IL-17 inhibitors: a systematic literature reviewBénédicte Caron, Jean-Yves Jouzeau, Pierre Miossec, et al.
Journal of Cellular Physiology|September 22, 2011
Association between the chondrocyte phenotype and the expression of adipokines and their receptors: evidence for a role of leptin but not adiponectin in the expression of cartilage-specific markersPierre-Jean Francin, Cécile Guillaume, Anne-Claude Humbert, et al.
International Journal of Oncology|March 9, 2005
Uncoupling of oxidative phosphorylation and Smac/DIABLO release are not sufficient to account for induction of apoptosis by sulindac sulfide in human colorectal cancer cellsMikael Daouphars, Meriem Koufany, Alexandre Benani, et al.
Bulletin De L'Academie Nationale De Medecine|June 7, 2021
[Reforming Biosciences and Health Research: Part I, Funding]Arnold Migus, Raymond Ardaillou, Patrick Berche, et al.
FEBS Letters|August 12, 2004
15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-1beta-induced IKK enzymatic activity and IkappaBalpha degradation in rat chondrocytes through a PPARgamma-independent pathwaySandrine Boyault, Arnaud Bianchi, David Moulin, et al.
Expert Opinion on Pharmacotherapy|July 4, 2023
Stemming the tide with ileocecal Crohn's disease: when is pharmacotherapy enough?Sophie Vieujean, Paulo Gustavo Kotze, Patrick Netter, et al.
Plos One|April 6, 2012
Xylosyltransferase-I regulates glycosaminoglycan synthesis during the pathogenic process of human osteoarthritisNarayanan Venkatesan, Lydia Barré, Mustapha Bourhim, et al.
Journal of Clinical Medicine|December 23, 2022
Inflammatory Bowel Disease Patients' Acceptance for Switching from Intravenous Infliximab or Vedolizumab to Subcutaneous Formulation: The Nancy ExperienceClotilde Remy, Bénédicte Caron, Celia Gouynou, et al.
Pageof 12